taxonomy (1)
protein (1)
source (4)
structure (42)
composition (45)
disease (2)
reference (4)
site (2)
peptide (5)
- Homo sapiens (Human)
Taxonomy
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Urine (UBERON_0001088)
Source
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ Gal(b1-4)"
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 3507
- N-Linked / Complex / Structure 32
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 2 x Gal(b1-4)"
- N-Linked / Complex / Structure 9453
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 1523
- N-Linked / Complex / Structure 9390
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)Gal(b1-4)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 9385
- N-Linked / Complex / Structure 9425
- N-Linked / Complex / Structure 9486
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 2 x Gal(b1-4) + NeuAc(a2-6)"
- N-Linked / Complex / Structure 9487
- N-Linked / Complex / Structure 9508
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-?)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 3 x Gal(b1-4)"
- N-Linked / Complex / Structure 1519
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 9372
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Structure 9499
- N-Linked / Complex / Structure 9512
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 9443
- N-Linked / Complex / Structure 9490
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 2 x NeuAc(a2-6)"
- N-Linked / Complex / Structure 9414
- N-Linked / Complex / Structure 9444
- N-Linked / High-Mannose / Man(a1-?)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 9371
- N-Linked / No-core / Fuc(?1-?)GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
Reported structure
- HexNAc:1 dHex:1 (avg mass : 367.3533 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1754.6234 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 dHex:2 (avg mass : 2015.8985 )
- Hex:3 HexNAc:6 dHex:3 (avg mass : 2162.0415 )
- Hex:4 HexNAc:2 (avg mass : 1072.9749 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2411.2187 )
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:4 dHex:4 (avg mass : 2226.0793 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2736.5316 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:4 (avg mass : 2956.7541 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. (1994 - Sutton C, O'Neill J, Cottrell J) / Status : Reviewed
Reference
- Metalloproteinase inhibitor 1 / Homo sapiens
Reported glycosite
- KFVGTPEVNQTTLYQRY (17aa)
- FVGTPEVNQTTLYQR (15aa)
- FVGTPEVNQTTIYQR (15aa)
- SHNRSEEFLIAGK (13aa)
- RSHNRSEEFLIAGKL (15aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1260.1705)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1422.3129)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1463.3655)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1666.5605)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1713.5708)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1828.7029)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1916.7658)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 1933.7933)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- KFVGTPEVNQTTLYQRY (17aa)
- RSHNRSEEFLIAGKL (15aa)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2079.9363)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2225.0512)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- KFVGTPEVNQTTLYQRY (17aa)
- RSHNRSEEFLIAGKL (15aa)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2226.0793)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2299.1307)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2356.1827)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- KFVGTPEVNQTTLYQRY (17aa)
- RSHNRSEEFLIAGKL (15aa)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2371.1942)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2445.2737)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2518.3251)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2518.3251)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2590.3886)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2735.5035)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2736.5316)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / Complex
(avg mass : 2956.7541)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / High-Mannose
(avg mass : 1072.9749)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Hybrid
(avg mass : 1422.3129)
- Milk (UBERON_0001913)
- Metalloproteinase inhibitor 1 / Homo sapiens
- RSHNRSEEFLIAGKL (15aa)
-
- N-Linked / No-core
(avg mass : 367.3533)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1713.5708)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:3 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1754.6234)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
- SHNRSEEFLIAGK (13aa)
-
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:3 HexNAc:6 dHex:2 / N-Linked
(avg mass : 2015.8985)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 1523
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)Gal(b1-4)"
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:5 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2136.9883)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:6 HexNAc:5 dHex:1 / N-Linked
(avg mass : 2152.9877)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / Structure 9385
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:3 HexNAc:6 dHex:3 / N-Linked
(avg mass : 2162.0415)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked
(avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2225.0512)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / Structure 9425
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2266.1038)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
- Urine (UBERON_0001088)
- N-Linked / Complex / Structure 1519
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- Prostate cancer (DOID:10283)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTLYQR (15aa)
-
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked
(avg mass : 2371.1942)
- Urine (UBERON_0001088)
- N-Linked / Complex / Structure 9372
- Prostate cancer (DOID:10283)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTLYQR (15aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2411.2187)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:6 HexNAc:7 / N-Linked
(avg mass : 2413.2347)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Metalloproteinase inhibitor 1 / Homo sapiens
- FVGTPEVNQTTIYQR (15aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:7 / N-Linked
(avg mass : 2413.2347)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2411.2187)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked
(avg mass : 2371.1942)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2266.1038)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2225.0512)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:6 dHex:2 / N-Linked
(avg mass : 2178.0409)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 dHex:3 / N-Linked
(avg mass : 2162.0415)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 / N-Linked
(avg mass : 2152.9877)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2136.9883)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 dHex:2 / N-Linked
(avg mass : 2015.8985)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1754.6234)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1713.5708)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
Source
Reported glycosite
Suggested glycosite
- N-Linked / No-core
(avg mass : 367.3533)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 1422.3129)
Source
Reported glycosite
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1072.9749)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2956.7541)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2736.5316)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2735.5035)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2590.3886)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2518.3251)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2518.3251)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2445.2737)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2371.1942)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2356.1827)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2299.1307)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2226.0793)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2225.0512)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2079.9363)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1933.7933)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1916.7658)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1828.7029)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1713.5708)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1666.5605)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1463.3655)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1422.3129)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1260.1705)